Article Information
History
- July 22, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nicholas Wooda,b,*,
- Laura K Lopeza,
- Catherine Glovera,
- Alan Leebc,d,
- Patrick Cashmane,
- Lucy Denga,b and
- Kristine Macartneya,b
- aNational Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead, Westmead, New South Wales, Australia
- bThe University of Sydney Children’s Hospital Westmead Clinical School, Westmead, New South Wales, Australia
- cSmartVax, Ballajura, Western Australia, Australia
- dlllawarra Medical Centre, Ballajura, Western Australia, Australia
- eHunter New England Population Health, Newcastle, New South Wales, Australia
- ↵*Address correspondence to:
Associate Professor Nicholas Wood, aNational Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead, Westmead, New South Wales, Australia. [nicholas.wood{at}health.nsw.gov.au]
Contributors’ Statement Page Associate Professor Wood, Dr Deng, Ms Glover and Dr Lopez conceptualized and designed the study, drafted the initial manuscript, and reviewed and revised the manuscript.
Dr Leeb and Mr Cashman designed the data collection instruments and reviewed and revised the manuscript.
Professor Macartney conceptualized and designed the study and critically reviewed the manuscript for important intellectual content.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Posted July 22, 2022.
Active safety surveillance of COVID-19 mRNA vaccines in children aged 5-15 years in Australia
